Open AccessSN-38 Sensitizes BRCA-Proficient Ovarian Cancers to PARP Inhibitors through Inhibiting Homologous Recombination Repair
Author(s) -
Shengbin Lin,
Jiaxin Tian,
Qiang He,
Minyi Yang,
Zuyang Chen,
Alexey A. Belogurov,
Xiao Li,
Fan Zhang,
Yongzhu Liu,
Guo Chen
Publication year - 2022
Publication title -
disease markers
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.912
H-Index - 66
eISSN - 1875-8630
pISSN - 0278-0240
DOI - 10.1155/2022/7243146
Subject(s) - olaparib , homologous recombination , parp inhibitor , poly adp ribose polymerase , ovarian cancer , cancer research , dna repair , dna damage , polymerase , biology , cancer , microbiology and biotechnology , dna , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom